Watch MDT. Know when insiders buy.
One email the day a filing lands. Free.
Work order
100
PASS · shorts 100
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 2
buys / sells · latest disclosed Sep 1
Big money
3 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP $120.5BP/E 23.1DIV YIELD —FCF YIELD 5.09%REV TTM $37.5B +9.8%NET INCOME $5.2B +12.3%NET DEBT $23.9B52W 73.75 – 105.35SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2027 · Jul 31 | $9.8B | +13.7% | 65.0% | $1.8B | $1.5B | +41.3% | 1.14 | $1.8B | $503M | $1.3B | Sep 3 |
| Q4 2026 · Apr 24derived | $9.8B | +9.9% | 65.4% | $1.9B | $1.2B | +17.8% | 0.97 | $2.6B | $488M | $2.1B | Jun 18 |
| Q3 2026 · Jan 23 | $9B | +8.7% | 63.8% | $1.5B | $1.1B | −11.7% | 0.89 | $2.7B | $444M | $2.3B | Feb 24 |
| Q2 2026 · Oct 24 | $9B | +6.6% | 65.8% | $1.7B | $1.4B | +8.2% | 1.07 | $925M | $468M | $457M | Feb 24 |
| Q1 2026 · Jul 25 | $8.6B | +8.4% | 65.0% | $1.4B | $1B | −0.2% | 0.81 | $1.1B | $504M | $584M | Sep 3 |
| Q4 2025 · Apr 25derived | $8.9B | +3.9% | 64.7% | $1.4B | $1.1B | +61.5% | 0.82 | $2.5B | $459M | $2.1B | Jun 18 |
| Q3 2025 · Jan 24 | $8.3B | +2.5% | 66.5% | $1.6B | $1.3B | −2.1% | 1.01 | $2.6B | $476M | $2.1B | Feb 24 |
| Q2 2025 · Oct 25 | $8.4B | +5.2% | 64.9% | $1.6B | $1.3B | +39.7% | 0.99 | $958M | $404M | $554M | Feb 24 |
| Q1 2025 · Jul 26 | $7.9B | — | 65.1% | $1.3B | $1B | — | 0.80 | $986M | $520M | $466M | Feb 24 |
| Q4 2024 · Apr 26derived | $8.6B | — | 64.6% | $1.1B | $654M | — | 0.49 | $2.8B | $426M | $2.4B | Jun 18 |
| Q3 2024 · Jan 26 | $8.1B | — | 65.6% | $1.5B | $1.3B | — | 0.99 | $2.5B | $346M | $2.1B | Feb 25 |
| Q2 2024 · Oct 27 | $8B | — | 65.4% | $1.3B | $909M | — | 0.68 | $661M | $461M | $200M | Feb 25 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 · to Apr 24 | $36.4B | 65.0% | $6.5B | $4.8B | 13.2% | 3.73 | $7.3B | $1.9B | $5.4B | $1B | $3.6B |
| FY2025 · to Apr 25 | $33.5B | 65.3% | $6B | $4.7B | 13.9% | 3.61 | $7B | $1.9B | $5.2B | $3.2B | $3.6B |
| FY2024 · to Apr 26 | $32.4B | 65.3% | $5.1B | $3.7B | 11.4% | 2.76 | $6.8B | $1.6B | $5.2B | $2.1B | $3.7B |
| FY2023 · to Apr 28 | $31.2B | 65.7% | $5.5B | $3.8B | 12.0% | 2.82 | $6B | $1.5B | $4.6B | $645M | $3.6B |
| FY2022 · to Apr 29 | $31.7B | 68.0% | $5.8B | $5B | 15.9% | 3.73 | $7.3B | $1.4B | $6B | $2.5B | $3.4B |
| FY2021 · to Apr 30 | $30.1B | 65.2% | $4.5B | $3.6B | 12.0% | 2.66 | $6.2B | $1.4B | $4.9B | $652M | $3.1B |
Every number comes from Medtronic plc's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.